Daniel R. Carter

2.1k total citations
38 papers, 898 citations indexed

About

Daniel R. Carter is a scholar working on Molecular Biology, Neurology and Immunology. According to data from OpenAlex, Daniel R. Carter has authored 38 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Neurology and 6 papers in Immunology. Recurrent topics in Daniel R. Carter's work include Neuroblastoma Research and Treatments (17 papers), interferon and immune responses (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Daniel R. Carter is often cited by papers focused on Neuroblastoma Research and Treatments (17 papers), interferon and immune responses (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Daniel R. Carter collaborates with scholars based in Australia, United States and Belgium. Daniel R. Carter's co-authors include Glenn M. Marshall, Belamy B. Cheung, Tao Liu, Marion K. Mateos, William A. Weiss, Justin Meyerowitz, Katleen De Preter, Tanya Clement, Frank Speleman and Zsuzsanna Nagy and has published in prestigious journals such as Nature Communications, Nature reviews. Cancer and Blood.

In The Last Decade

Daniel R. Carter

36 papers receiving 881 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel R. Carter Australia 17 493 266 215 121 85 38 898
Erin L. Sausville United States 5 473 1.0× 98 0.4× 139 0.6× 186 1.5× 71 0.8× 6 976
Darcy Franicola United States 18 460 0.9× 63 0.2× 145 0.7× 116 1.0× 49 0.6× 65 895
Chenhui Zhao China 15 385 0.8× 126 0.5× 199 0.9× 88 0.7× 116 1.4× 47 1.0k
Mahdi Jalili Iran 14 380 0.8× 76 0.3× 78 0.4× 51 0.4× 40 0.5× 60 783
Ewa Nowak‐Markwitz Poland 19 564 1.1× 47 0.2× 293 1.4× 432 3.6× 236 2.8× 110 1.4k
Timothy J. Wallace United States 12 453 0.9× 34 0.1× 473 2.2× 308 2.5× 86 1.0× 19 1.2k
Catriona Parker United Kingdom 13 316 0.6× 41 0.2× 151 0.7× 234 1.9× 45 0.5× 28 852
Amy M. Fowler United States 22 327 0.7× 118 0.4× 459 2.1× 558 4.6× 85 1.0× 88 1.7k
Kristen M. John United States 3 329 0.7× 95 0.4× 39 0.2× 136 1.1× 53 0.6× 5 745
Andrew Dhawan United States 16 484 1.0× 50 0.2× 359 1.7× 313 2.6× 112 1.3× 57 1.1k

Countries citing papers authored by Daniel R. Carter

Since Specialization
Citations

This map shows the geographic impact of Daniel R. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel R. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel R. Carter more than expected).

Fields of papers citing papers by Daniel R. Carter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel R. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel R. Carter. The network helps show where Daniel R. Carter may publish in the future.

Co-authorship network of co-authors of Daniel R. Carter

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel R. Carter. A scholar is included among the top collaborators of Daniel R. Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel R. Carter. Daniel R. Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mayoh, Chelsea, Katleen De Preter, Frank Speleman, et al.. (2023). MYCN and SNRPD3 cooperate to maintain a balance of alternative splicing events that drives neuroblastoma progression. Oncogene. 43(5). 363–377. 5 indexed citations
3.
Thoms, Julie A.I., Kathy Knezevic, Yizhou Huang, et al.. (2021). Disruption of a GATA2-TAL1-ERG regulatory circuit promotes erythroid transition in healthy and leukemic stem cells. Blood. 138(16). 1441–1455. 22 indexed citations
4.
Nagy, Zsuzsanna, William K. Chang, Chelsea Mayoh, et al.. (2021). An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability. Nature Communications. 12(1). 1881–1881. 54 indexed citations
5.
Zimmerman, Mark W., Nina Weichert‐Leahey, Belamy B. Cheung, et al.. (2021). MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation. Cancers. 13(19). 4783–4783. 9 indexed citations
6.
Trayner, Kirsten M. A., Norah Palmateer, Andrew McAuley, et al.. (2021). Evaluation of the scale-up of HIV testing among people who inject drugs in Scotland in the context of an ongoing HIV outbreak. International Journal of Drug Policy. 96. 103304–103304. 8 indexed citations
7.
Nagy, Zsuzsanna, et al.. (2020). Withaferin A activates TRIM16 for its anti-cancer activity in melanoma. Scientific Reports. 10(1). 19724–19724. 35 indexed citations
8.
Sutton, Selina K., Belamy B. Cheung, Hassina Massudi, et al.. (2019). Heterozygous loss of keratinocyte TRIM16 expression increases melanocytic cell lesions and lymph node metastasis. Journal of Cancer Research and Clinical Oncology. 145(9). 2241–2250. 10 indexed citations
9.
Hu, Xinjie, Weisheng Zheng, Qianshu Zhu, et al.. (2019). Increase in DNA Damage by MYCN Knockdown Through Regulating Nucleosome Organization and Chromatin State in Neuroblastoma. Frontiers in Genetics. 10. 684–684. 5 indexed citations
10.
Carter, Daniel R., Bing Liu, Chelsea Mayoh, et al.. (2018). Network Modeling of microRNA–mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN. Cancer Research. 78(12). 3122–3134. 45 indexed citations
11.
Fischer, Matthias, Thomas F.E. Barth, Wolfgang Mueller‐Klieser, et al.. (2018). LDHA in Neuroblastoma Is Associated with Poor Outcome and Its Depletion Decreases Neuroblastoma Growth Independent of Aerobic Glycolysis. Clinical Cancer Research. 24(22). 5772–5783. 54 indexed citations
12.
Cheung, Belamy B., Owen Tan, Jessica Koach, et al.. (2015). Thymosin‐β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma. Molecular Oncology. 9(7). 1484–1500. 15 indexed citations
13.
Beckers, Anneleen, Gert Van Peer, Daniel R. Carter, et al.. (2015). MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma. Cancer Letters. 366(1). 123–132. 33 indexed citations
14.
Beckers, Anneleen, Andrew D. Ludwig, Gert Van Peer, et al.. (2014). The MYCN/miR-26a-5p/LIN28B regulatory axis controls MYCN-driven LIN28B upregulation in neuroblastoma. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
15.
Marshall, Glenn M., Daniel R. Carter, Belamy B. Cheung, et al.. (2014). The prenatal origins of cancer. Nature reviews. Cancer. 14(4). 277–289. 184 indexed citations
16.
Carter, Daniel R., et al.. (2014). Art27 Interacts with GATA4, FOG2 and NKX2.5 and Is a Novel Co-Repressor of Cardiac Genes. PLoS ONE. 9(4). e95253–e95253. 16 indexed citations
17.
Michimi, Akihiko, et al.. (2013). Dental caries among children visiting a mobile dental clinic in South Central Kentucky: a pooled cross-sectional study. BMC Oral Health. 13(1). 19–19. 28 indexed citations
18.
Tan, Owen, Sonya M. Diakiw, Daniel R. Carter, et al.. (2013). Identification of plasma Complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach. Journal of Proteomics. 96. 1–12. 16 indexed citations
19.
Perdomo, José, Xing‐Mai Jiang, Daniel R. Carter, Levon M. Khachigian, & Beng H. Chong. (2012). SUMOylation Regulates the Transcriptional Repression Activity of FOG-2 and Its Association with GATA-4. PLoS ONE. 7(11). e50637–e50637. 9 indexed citations
20.
Carter, Daniel R., et al.. (1998). Sudden Death Due to Undetected Mediastinal Germ Cell Tumor. American Journal of Forensic Medicine & Pathology. 19(1). 69–71. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erin L. Sausville Breakdown of academic impact, for papers by Darcy Franicola Breakdown of academic impact, for papers by Chenhui Zhao Breakdown of academic impact, for papers by Mahdi Jalili Breakdown of academic impact, for papers by Ewa Nowak‐Markwitz Breakdown of academic impact, for papers by Timothy J. Wallace Breakdown of academic impact, for papers by Catriona Parker Breakdown of academic impact, for papers by Amy M. Fowler Breakdown of academic impact, for papers by Kristen M. John Breakdown of academic impact, for papers by Andrew Dhawan
Rankless by CCL
2026